Javascript must be enabled to continue!
Mass in Male (Gynecomastia, Cancer)
View through CrossRef
Abstract
Gynecomastia is a benign condition manifesting as enlarged breasts in men and boys. This increased breast tissue is caused by excess fibroglandular deposits and is caused by hormonal imbalances, commonly due to estrogen excess or from various drugs, such as spironolactone, ketoconazole, cimetidine, ranitidine, and specific HIV therapies. Patients generally present with bilateral subareolar enlarged breasts (however, unilateral gynecomastia also occurs), which commonly exhibit tenderness on palpation, swelling, palpable lumps, or nipple discharge. This chapter reviews the important imaging protocols, pitfalls, differential diagnoses, radiology–pathology correlation, and management recommendations for gynecomastia and cancer of the male breast. Topics discussed include gynecomastia, breast cancer, pseudogynecomastia, hypogonadism, and lymphangioma.
Title: Mass in Male (Gynecomastia, Cancer)
Description:
Abstract
Gynecomastia is a benign condition manifesting as enlarged breasts in men and boys.
This increased breast tissue is caused by excess fibroglandular deposits and is caused by hormonal imbalances, commonly due to estrogen excess or from various drugs, such as spironolactone, ketoconazole, cimetidine, ranitidine, and specific HIV therapies.
Patients generally present with bilateral subareolar enlarged breasts (however, unilateral gynecomastia also occurs), which commonly exhibit tenderness on palpation, swelling, palpable lumps, or nipple discharge.
This chapter reviews the important imaging protocols, pitfalls, differential diagnoses, radiology–pathology correlation, and management recommendations for gynecomastia and cancer of the male breast.
Topics discussed include gynecomastia, breast cancer, pseudogynecomastia, hypogonadism, and lymphangioma.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
The Black Mass as Play: Dennis Wheatley's The Devil Rides Out
The Black Mass as Play: Dennis Wheatley's The Devil Rides Out
Literature—at least serious literature—is something that we work at. This is especially true within the academy. Literature departments are places where workers labour over texts c...
Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia
Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia
Idiopathic gynecomastia, unilateral or bilateral, is a common physical finding in normal men. Successful treatment using tamoxifen (antiestrogen) and danazol (antiandrogen) has rec...
Overview on Epidemiology, Causes and Management of Gynecomastia
Overview on Epidemiology, Causes and Management of Gynecomastia
Background: Gynecomastia is characterized by the benign enlargement of male breast tissue, a condition witnessed across varied age brackets and influenced by several factors. While...
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED]Rhino XL Reviews, NY USA: Studies show that testosterone levels in males decrease constantly with growing age. There are also many other problems that males face due ...
Spironolactone-digoxin synergizes gynecomastia: A case report
Spironolactone-digoxin synergizes gynecomastia: A case report
Gynecomastia refers to a proliferation of breast tissue in the males that causes imbalances in estrogen and androgen levels, resulting in increased or unopposed estrogen action on ...
Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia
Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia
Abstract
Gynecomastia, characterized by the benign enlargement of male breast tissue, has a lifetime prevalence of 65% and can significantly impact quality of lif...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

